About us

Lawarence press is an information solution company’s endeavour to bring information among research professionals of the health, science and technology sectors.
We publish contents with the mission to provide information which is universally accessible. We provide easily accessible and elegant online publishing solutions.
Our mission is to empower research work providing web-based digital publishing platform solutions of an international standard. .
Our company vision is to provide the highest standard in an online publishing platform.
We value innovation, originality & quality.

Construction of Brain-Targeted Nanoreactor System and Intracerebral Drug Delivery

Shan Wang, Yanci Chen, Feng Gao, Xi Li, Yiyun Huang, Ying Luo, QingPing, Zeng, Qing Zheng

Abstract


Poly(lactic-co-glycolic acid (PLGA) copolymer) nanoparticles with an average particle diameter of 142.8 nm and a polydispersity of 0.161 were prepared and optimized by an emulsion solvent evaporation method. Blank nanoparticles were modified with the transmembrane peptide (trans-activator of transcription, TAT) and the brain-targeting peptide (Angiopep-2), and the modification rate was determined. It is obvious that the modification rates of TAT and Angiopep-2 were 65.4% and 71.1%. After the preparation of coumarin-6-loaded nanoparticles, high-performance liquid chromatography analysis method was established, the entrapment efficiency, drug loading capacity (DLC) and drug release properties of chaudoulen-6 nanoparticles were determined. It was indicated that the entrapment efficiency of coumarin-6 nanoparticles was 38.21%, DLC was 0.229%, with a sustained release effect within 48 h. Fluorescence imaging technology was used to explore the targeting of nanoparticles in mice. TAT and Angiopep-2 modified nanoparticles exhibited strong brain targeting effects.

Keywords


nano-release system, polylactic acid-glycolic acid copolymer, brain-targeting peptides, cell-penetrating peptides

Full Text:

References


Honjo K, Black SE, Verhoeff NP. Alzheimer’s disease, cerebrovascular disease, and the ?-amyloid cascade. Can J Neurol Sci.2012;39:712–728.

Abbott A. Dementia: a problem for our age. Nature. 2011;475:S2–S4.

Greenwald RB, Choe YH, McGuire J, Conover CD. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev.2003;55:217–250.

Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev. 2005;57:529–545.

Demeule M, Régina A, Ché C, Poirier J, Nguyen T, Gabathuler R, et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther.2008;324:1064–1072.

Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V.Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-

co-glycolide) nanoparticles. Int J Pharm. 2003;262:1–11.

Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nat Methods. 2005;2:905–909.

Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science. 2009;324:804–807.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.